Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival

NCT07731425 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
3000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

London School of Economics and Political Science

Collaborators